Cheng Sohanya Roshan

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
7
Insider Sells Sum
$84,140.75

Insider Activity of Cheng Sohanya Roshan

According to the SEC Form 4 filings, Cheng Sohanya Roshan, being in a position of

  1. EVP & Chief Commercial Officer at Karyopharm Therapeutics Inc.,
    оver the last 12 months, has bought 0 shares, and sold 32305 shares for $35,550,
    over all time since 2022-06-13, has bought 0 shares, and sold 52864 shares for $84,141.

The largest sale of all time was on 2023-03-01 and amounted to 11239 shares of Karyopharm Therapeutics Inc. for $34,045.

Biography of Cheng Sohanya Roshan

No biography is available at this moment.

2024-09-04SaleKaryopharm Therapeutics Inc.
KPTI
EVP & Chief Commercial Officer
5,356
0.0044%
$0.72$3,866+4.49%
2024-03-01SaleKaryopharm Therapeutics Inc.
KPTI
EVP & Chief Commercial Officer
5,109
0.0045%
$1.20$6,131-14.29%
2024-02-29SaleKaryopharm Therapeutics Inc.
KPTI
EVP & Chief Commercial Officer
21,840
0.0199%
$1.17$25,553-12.07%
2023-09-01SaleKaryopharm Therapeutics Inc.
KPTI
EVP & Chief Commercial Officer
7,415
0.0064%
$1.33$9,872-24.26%
2023-06-08SaleKaryopharm Therapeutics Inc.
KPTI
EVP & Chief Commercial Officer
1,839
0.0016%
$2.35$4,322-48.29%
2023-03-01SaleKaryopharm Therapeutics Inc.
KPTI
EVP & Chief Commercial Officer
11,239
0.0097%
$3.03$34,045-55.02%
2022-06-13SaleKaryopharm Therapeutics Inc.
KPTI
Chief Commercial Officer
66
<0.0001%
$5.34$353-14.17%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.